PL · Planet Labs PBC · Stock research

Current Thesis

The unwind that began when SpaceX listed on 6/12 has not found a floor. Planet Labs lost the ~$42 breakout shelf on the 6/4 print, sliced the $32 post-earnings low, based briefly in the mid-$20s, then broke that too 7/16 closed down 7.8% from $24.90 to $22.97, and 7/18 traded $21.03–$23.29 to settle near $22.58. That is roughly 56% off the $51.40 all-time closing high set 5/28, with a $7.90B market cap. Both the 50-DMA at $35.40 and the 200-DMA at $30.60 sit far above spot and are still declining, so every prior support level is now overhead supply.

The company is not the problem. Revenue is compounding above 40%, backlog is up 79%, and FY26 was the first year of positive adjusted EBITDA and free cash flow. What broke is the ownership base. The $1.5B at-the-market equity program filed 6/5 was ~16% of the market cap when announced; after the drawdown it is ~19% of $7.90B, meaning the dilution overhang mechanically got heavier as the stock fell. A continuous-offering lid on a name whose marginal buyer was a SpaceX-IPO proxy trade that no longer exists is a structure that grinds rather than bounces. Fresh capital has no edge here until an actual base forms.

Bullish and bearish views on Planet Labs PBC

The model's bull view on Planet Labs PBC (PL), in brief: Q1 FY27 (6/4): revenue $94.15M, +42% YoY, beat the $89.85M consensus; adjusted EPS $(0.03) vs $(0.04) expected a record quarter on both lines. The bear view: The 7/16 -7.8% session broke the mid-$20s consolidation that had held since late June. Both cases follow in full.

Bull Case

• Q1 FY27 (6/4): revenue $94.15M, +42% YoY, beat the $89.85M consensus; adjusted EPS $(0.03) vs $(0.04) expected a record quarter on both lines.
• FY27 guidance raised 6/4 to $425–441M; Q2 guided $102–107M against $101.09M Street.
• Backlog above $900M, +79% YoY, with remaining performance obligations +106% to $852M (Q4 FY26, 3/19) the guide is contracted revenue, not pipeline optimism.
• ~$731M cash as of July against no near-term funding cliff; FY26 delivered $15.5M adjusted EBITDA and $52.9M free cash flow, the first positive year for each.
• Valuation has compressed hard: ~$7.90B cap against the $433M FY27 guide midpoint is ~18x sales, down from ~31x at the June highs and ~46x at the May peak.
• Sell-side has not followed price down Goldman raised its target to $25 from $22 on 7/14 (Neutral), Wedbush reiterated Outperform $50 on 7/1, Needham $53 and Craig-Hallum $49 from 6/5. Consensus target is $35.36 on 6 Buy / 4 Hold / 2 Sell.
• Commercial execution continues independent of the tape: Planet Labs Germany signed Isar Aerospace to introduce Pelican satellites (7/2), Pelican-11 launched in early July, and Planet Federal's Maritime Domain Awareness extension plus a new global-monitoring award landed 6/4.

Bear Case

• The 7/16 -7.8% session broke the mid-$20s consolidation that had held since late June. A range that fails to the downside converts every buyer inside it into trapped supply.
• The $1.5B ATM is continuous, not a single priced deal there is no clearing event to trade against, just persistent offer into strength until it is absorbed.
• Margin direction is wrong alongside the revenue raise: gross margin steps down from 56% in Q1 to a 52–54% FY27 guide while capex runs $80–95M. Growth is being bought.
• Insider flow is entirely one way. Director John Raymond sold 6,494 at $26.16 on 7/13. Quarterly insider disposals total 96,087 shares for $2.49M with no offsetting open-market purchases.
• Analyst dispersion between Goldman's $25 and Wedbush's $50 is a warning, not a margin of safety. The high targets are stale relative to the tape; downward revisions are the more likely next adjustment.
• The 6/29 +15.4% pop came from Rocket Lab's move on Iridium sector beta, not company news and failed well below the broken shelf. That lower high is the cleanest evidence rallies are being sold.
• "Space Stocks In June Gloom" (6/25) documented the cluster giving back its 2026 gains once the SpaceX listing removed the narrative fuel. The proxy bid is gone and nothing has replaced it.
• GAAP profitability is not modeled until 2028, which leaves the equity dependent on multiple support in a tape that is actively compressing multiples.

Setup & Price Structure

Price is below every relevant moving average, and the averages are stacked in bearish order with the 50-DMA ($35.40) above the 200-DMA ($30.60) but rolling toward a cross. Spot near $22.58 sits ~36% below the 50-DMA deeply extended to the downside, which produces sharp counter-trend bounces but has not produced a higher low since late May.

The sequence is unambiguous: $51.40 high (5/28) → lost $42 on a record beat (6/4) → through $32 → mid-$20s consolidation → broken 7/16. Four distinct support levels have failed in six weeks. The 7/18 low near $21.03 is the only structure the stock currently owns, and it is one day old.

Theme state is best described as post-mania rather than accelerating. The saturation markers that flagged the top UFO ETF crossing $1B AUM (5/28), NASA-ETF inflow mania (5/24, 5/30) have given way to the distribution phase where mainstream coverage turns from opportunity to explanation. In this configuration the correct stance is to let a base build and pay up for confirmation, rather than bid a falling knife at what looks like a discount to a $35 consensus target.

Catalyst Calendar (next 30 days)

• ~2026-08-15 (est.): the ATM program's practical pricing window continues; any 424(b) or 8-K disclosing shares issued and average price would define the actual dilution rate and is the single most tradeable filing for this name.
• ~2026-08-20 (est.): Pelican-class deployment and commissioning updates following the early-July Pelican-11 launch capacity milestones that feed the FY28 revenue bridge.
• No earnings in the window. Q2 FY27 is estimated for early-September 2026, so there is no binary print risk between now and mid-August.
• Ongoing: European government program awards (Greek national satellite program from 5/7, Czech AI ag-monitoring via Sinergise from 5/13) can land without a scheduled date; these are the least rate-sensitive part of the revenue mix.

What Would Change Our Mind

The bearish read stops working on evidence of absorption rather than on a bounce. Specifically: a weekly reclaim of the $30.60 200-DMA on expanding volume, following a confirmed higher low above the $21 area, would mark the ATM as digested and the downtrend as over. A completed and disclosed ATM drawdown at a known average price would remove the open-ended supply question and is arguably a bigger unlock than any contract award.

On the fundamental side, a Q2 print in early September that holds the 52–54% gross margin guide while raising FY27 again would confirm that the margin step-down was a one-time capacity investment rather than a structural reset. Conversely, evidence that the story is truly broken would be a guide cut, a large customer non-renewal in the government book, or a peer failure inside the cluster any of which would push this from a stand-aside into a name with no path back.

Correlation Notes

PL trades as a single risk unit with RKLB, ASTS, LUNR, Redwire, Momentus and Firefly. Position sizing across two or more of these is one theme bet, not diversification the 6/29 +15.4% move on Rocket Lab's Iridium news and the shared 6/25 drawdown both demonstrate the correlation runs near one on theme-level catalysts.

Secondary correlations worth tracking: defense budget headlines and European rearmament flow (the government geospatial revenue layer), and broad high-multiple growth risk appetite the 7/16 Nasdaq 100 semiconductor selloff coincided with the PL breakdown, so the name still carries beta to unprofitable-growth de-risking regardless of company-specific news. Institutional ownership at 41.71%, with AQR and Goldman shown adding in the most recent 13F snapshots, reflects positioning taken largely before the June-July collapse and should not be read as current conviction.